# mClinica Pte.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/mclinica-pte

- Industry: Internet
- Headquarters: Singapore, Singapore
- Website: www.swiperxapp.com
- Total disclosed funding: $34M
- Latest round: Series B (Feb 9, 2023)
- Investors on record: 13

## About

mClinica Pte. Ltd. is a specialized B2B commerce platform that enhances pharmacy operations across Southeast Asia by offering a community space, education resources, and efficient procurement solutions.Founded in 2012 and headquartered in Singapore, mClinica Pte. Ltd. operates as a B2B commerce platform specifically crafted for pharmacy professionals. The company has successfully raised USD 8.75 mn in Series B funding on 2023-02-09, with investors including Sanofi Ventures and Cercano Management. The founder, Farouk Meralli, has led the company through five distinct funding rounds, culminating in a total raised amount of USD 8.75 mn and achieving a current valuation of USD 83.75 mn.SwipeRx operates as a comprehensive community and B2B commerce platform tailored specifically for pharmacy professionals across Southeast Asia. At the core of its offerings are accredited CPD education modules, a B2B commerce tool for purchasing high-quality and affordable medicines, and a suite of features designed to facilitate collaboration among pharmacy professionals. The platform serves over 300,000 pharmacy professionals, including 100,000 who have participated in its digital education initiatives, and more than 50,000 retail pharmacies in various countries including Indonesia, the Philippines, Malaysia, and Thailand. By providing essential resources such as industry news, adverse event reporting, and a drug directory, SwipeRx addresses the critical needs of pharmacies seeking to enhance their operational efficiency and maintain up-to-date professional knowledge.In 2023, SwipeRx generated revenue of USD 19.44 mn alongside an EBITDA of USD -5.82 mn. Revenue is derived from a structured B2B commerce model where retail pharmacies procure medicines and pharmacy-related products directly from suppliers, supported by partnerships with pharmaceutical manufacturers. Additionally, SwipeRx monetizes its platform by offering subscription-based access to accredited CPD education modules, which allows pharmacy professionals to earn continuing education credits.In February 2023, mClinica Pte. Ltd. raised USD 8.75 mn in Series B funding to invest in specialized healthcare logistics and financing, expand its pharmacy network in Southeast Asia, and strengthen its advanced data teams. The company aims to enhance its offerings and forge deeper connections within its community, with plans for growth in key markets across the region.

## Funding rounds

- Series B, Feb 9, 2023, $8.8M — Johnson & Johnson Innovation, Susquehanna International Group, Sanofi Ventures, Patamar Capital, Cercano Management
- Series B, Dec 7, 2022, $19M — Gates Foundation Trust, Johnson & Johnson Innovation, SAI360 Inc., Susquehanna International Group, Patamar Capital, MDI Ventures, Global Innovation Fund
- Series A, Mar 30, 2017, $6.4M — 500 Global, Endeavor Catalyst, Kickstart Ventures, Spiral Ventures, Patamar Capital, MDI Ventures, Global Innovation Fund
- Seed, Jul 2, 2014, $0.5M — 500 Global, Kickstart Ventures, Spiral Ventures

## Investors

- 500 Global (https://capitalatlas.ai/funds/500-global) — Seed, Series A
- Kickstart Ventures (https://capitalatlas.ai/funds/kickstart-ventures) — Seed, Series A
- Spiral Ventures (https://capitalatlas.ai/funds/spiral-ventures) — Seed, Series A
- Endeavor Catalyst (https://capitalatlas.ai/funds/endeavor-catalyst) — Series A
- Patamar Capital (https://capitalatlas.ai/funds/patamar-capital) — Series A, Series B
- MDI Ventures (https://capitalatlas.ai/funds/mdi-ventures) — Series A, Series B
- Global Innovation Fund (https://capitalatlas.ai/funds/global-innovation-fund) — Series A, Series B
- Gates Foundation Trust — Series B
- Johnson & Johnson Innovation (https://capitalatlas.ai/funds/johnson-johnson-innovation) — Series B
- SAI360 Inc. — Series B
- Susquehanna International Group — Series B
- Sanofi Ventures (https://capitalatlas.ai/funds/sanofi-ventures) — Series B
- Cercano Management (https://capitalatlas.ai/funds/cercano-management) — Series B